TGFB1 and adenocarcinoma: The Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2) promotes EMT when activated, whereas genetic silencing of SHP2, or its pharmacological inhibition, blocks the TGFβ-induced EMT in A549 adenocarcinoma cells [114].